LSBCF (LakeShore Biopharma Co) Interest Expense: $-2.19 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Interest Expense?

LakeShore Biopharma Co LSBCF Interest Expense is $-2.19 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. LakeShore Biopharma Co's interest expense for the six months ended in Mar. 2025 was $ -1.26 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-2.19 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. LakeShore Biopharma Co's Operating Income for the six months ended in Mar. 2025 was $ -10.92 Mil. LakeShore Biopharma Co's Interest Expense for the six months ended in Mar. 2025 was $ -1.26 Mil. LakeShore Biopharma Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LakeShore Biopharma Co  (OTCPK:LSBCF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LakeShore Biopharma Co's Interest Expense for the six months ended in Mar. 2025 was $-1.26 Mil. Its Operating Income for the six months ended in Mar. 2025 was $-10.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2025 was $3.24 Mil.

LakeShore Biopharma Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

LakeShore Biopharma Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

LakeShore Biopharma Co Interest Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Interest Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Interest Expense
-4.56 -0.43 -4.48 -6.16 -2.17

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only -2.27 -1.78 -4.36 -0.93 -1.26

LakeShore Biopharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-2.19 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Interest Expense of $-2.19 Mil as of Mar. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Interest Expense too high?
LakeShore Biopharma Co's current Interest Expense is $-2.19 Mil.
How does LakeShore Biopharma Co's Interest Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Interest Expense of $-2.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Interest Expense is $-2.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Interest Expense of $-2.19 Mil. The current Interest Expense is $-2.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Interest Expense is $-2.19 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.